Scopus Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.4M Buy
+866,500
New +$75.8M 1.12% 11
2023
Q4
Sell
-537,500
Closed -$38.2M 243
2023
Q3
$38.2M Buy
537,500
+132,500
+33% +$9.91M 1.09% 26
2023
Q2
$31.2M Buy
+405,000
New +$31.3M 0.87% 39
2023
Q1
Sell
-887,500
Closed -$69.9M 229
2022
Q4
$69.9M Buy
887,500
+237,500
+37% +$17.8M 1.9% 4
2022
Q3
$45.7M Buy
650,000
+50,000
+8% +$3.92M 1.69% 8
2022
Q2
$48.1M Buy
+600,000
New +$46.9M 2.65% 5
2021
Q3
Sell
-700,000
Closed -$56.9M 367
2021
Q2
$56.9M Buy
+700,000
New +$57.2M 0.74% 34
2021
Q1
Sell
-650,000
Closed -$55.6M 380
2020
Q4
$55.6M Buy
+650,000
New +$53.7M 0.89% 21
2017
Q2
Sell
-350,000
Closed -$25.6M 254
2017
Q1
$25.6M Buy
+350,000
New +$24.5M 0.39% 88

Other funds holding CL

Scopus Asset Management's CL Position: Q2 2026 in Review

Scopus Asset Management opened a new position in Colgate-Palmolive (CL) in Q2 2026: 866,500 shares worth $79.4M. The stake represents 1.12% of the portfolio and ranks #11 among its holdings. This is a return to the name: Scopus Asset Management previously reported a position in CL as recently as Q3 2023.

Scopus Asset Management first reported a position in CL in Q1 2017 and has held it in 9 quarters since. 2,021 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Scopus Asset Management held 866,500 shares of Colgate-Palmolive worth $79.4M as of Q2 2026.
  • Colgate-Palmolive was a new Scopus Asset Management position in Q2 2026.
  • Colgate-Palmolive made up 1.12% of Scopus Asset Management's portfolio in Q2 2026, its #11 holding.
  • Scopus Asset Management first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 9 quarters since.
  • 2,021 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Scopus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.